“Anti-SARS-CoV-2 Inactivated Vaccine in Patients With ANCA-Associated Vasculitis: Immunogenicity, Safety, Antibody Decay and the Booster Dose”. Clinics, vol. 78, Nov. 2022, p. 100150, https://doi.org/10.1016/j.clinsp.2022.100150.